Flexion Therapeutics, Inc. [•] Shares Common Stock ($0.001 par value) Underwriting AgreementFlexion Therapeutics Inc • January 29th, 2014 • Pharmaceutical preparations • New York
Flexion Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, [•] shares of common stock, $0.001 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to [•] additional shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the
OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS INC DATE: 3RD SEPTEMBER, 2010Licence Agreement • January 29th, 2014 • Flexion Therapeutics Inc • Pharmaceutical preparations • England
NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:
CONVERSION, AMENDMENT AND WAIVER AGREEMENTConversion, Amendment and Waiver Agreement • January 29th, 2014 • Flexion Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS CONVERSION, AMENDMENT AND WAIVER AGREEMENT (this “Agreement”) is made and entered into as of January 27, 2014, by and among FLEXION THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the undersigned stockholders of the Company (the “Stockholders”).
